Comparing low vs high oxytocin in labor for women with BMI 30+
Part of Hormones & metabolism clinical trials.
This trial compares a lower dose of the labor medicine oxytocin to a higher dose in women with a BMI of 30 or higher. It aims to find the safest and most effective way to start or speed up labor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 37 weeks pregnant (full term) and no more than 42 weeks.
- You have a BMI of 30 or higher.
- You need the medicine oxytocin to start or help your labor progress.
- You are carrying a single baby who is head-down (cephalic presentation).
- You have no reason that vaginal delivery is unsafe for you or your baby.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether gently stimulating the nipples can help trigger labor in pregnant people who are ready to deliver. Researchers want to know if it's safe, effective, and acceptable to patients and healthcare providers.
This study tests starting labor in women with a BMI of 40 or higher. The goal is to learn if certain methods are safe and effective for this group.
This study looks at the best timing to start labor (induction) during pregnancy for people with a higher body weight. It may help reduce risks by comparing earlier vs later induction in otherwise eligible pregnancies.
This study tests whether adding papaverine, a smooth-muscle relaxant, to the standard labor-inducing drug oxytocin can make labor quicker and safer. It is for first-time mothers carrying a single baby head-down who need to start labor with oxytocin.
This study compares two doses of oxytocin (a medicine given during cesarean section to prevent heavy bleeding) to see which works better for women with high-risk pregnancies. If you are having a planned cesarean and have certain risk factors, this trial may help find the best dose for you.
This trial tests whether giving a drug called propranolol (a beta-blocker) can shorten the time between starting labor induction and delivery for women who are getting oxytocin. If you are having a single baby in head-down position at full term, this study might be relevant to you.
Hear when a new Induction of Labor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.